Key Meet On COVID-19 Vaccine Approval Today, Day Before Pan-India Dry Run | Read

  • 3:32
  • Published On: January 01, 2021
Cinema View
Embed
Applications for the emergency use approval for the coronavirus vaccines filed by the Serum Institute of India, Bharat Biotech and Pfizer will be taken up once again for consideration by a government-appointed panel of experts today. Serum Institute which is making the vaccine 'Covishield' developed by Oxford University and pharma major AstraZeneca and Bharat Biotech which has partnered the Indian Council of Medical Research (ICMR) for its 'Covaxin' had made presentations before the panel on Wednesday. Pfizer had sought more time to present their data.

Related Videos

3 Indian Vaccines Approved For Use On Children
April 27, 2022 3:35
Covaxin Cleared For 6-12 Age Group
April 26, 2022 2:47
Covishield, Covaxin Cleared For Market Approval By Expert Panel
January 19, 2022 8:12
The Biggest Stories Of January 19, 2022
January 19, 2022 15:32
Covaxin Nod For Kids May Take Much Less Time: WHO Chief Scientist To NDTV
November 03, 2021 7:36
Top News of The Day: Covaxin, India-Made Vaccine Against Covid, Cleared By WHO
November 03, 2021 17:50
"Shouldn't Overreact To Delays In Covaxin Approval": Biocon's Kiran Shaw To NDTV
November 03, 2021 25:09
Covaxin For India And The World
November 03, 2021 23:47
Covaxin Gets WHO Approval, Finally
November 03, 2021 2:46
ICMR Has A New Report On Mix-And-Match Vaccines: The Way Forward
August 10, 2021 23:09
Mixing Covishield With Covaxin - Will It Work For India?
August 10, 2021 5:52
Covid Vaccine Dry Run Continues In Tamil Nadu
July 08, 2021 2:18
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination